Abstract
Myeloperoxidase (MPO) has been involved in the pathogenesis of several diseases through excessive production of reactive oxygen species (ROS) as well as through its genetic polymorphism. The aims of this study were to identify the factors affecting MPO serum concentration, to study the familial resemblance of MPO levels and to investigate the association between newly described MPO polymorphisms as well as the G-463A one and MPO levels in a healthy population. MPO serum concentrations were measured by an enzymatic immuno-assay (EIA) in 82 healthy families of the STANISLAS Cohort and MPO genotype, determination was performed using PCR-restriction fragment length polymorphism or allele specific oligonucleotide assay. MPO concentrations were significantly higher in parents than in offspring. The factors affecting MPO levels were age, the number of white cells, smoking in fathers and oral contraceptive intake in mothers. They explain from 12.4% up to 35.9% of MPO variability in men and women, respectively. Family correlations of MPO concentrations were of similar magnitude. The -129A allele of a newly described G-129A substitution was significantly associated with decreased MPO levels, whereas the -463A allele was suggested to be associated with increased levels of lipid variables. In this study, we identified factors affecting MPO serum concentrations and showed that molecular variations of the gene have only a weak influence on MPO variability. In contrast, the association between the G-463A polymorphism and lipid levels would suggest a possible implication of MPO in the risk of cardiovascular diseases. These results have to be confirmed and further investigations will be conducted in that way.
Similar content being viewed by others
Article PDF
References
Bainton DF, Ullyot JL, Farquhar MG . The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. Origin and content of azurophil and specific granules J Exp Med 1971 134: 907–934
Klebanoff SJ . Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes Science 1970 169: 1095–1097
Elneihoum AM, Falke P, Hedblad B, Lindgärde F, Ohlsson K . Leukocyte activation in atherosclerosis: correlation with risk factors Atherosclerosis 1997 131: 79–84
Tischendorf FW, Brattig NW, Büttner DW, Pieper A, Lintzel M . Serum levels of eosinophil cationic protein, eosinophil-derived neurotoxin and myeloperoxidase in infections with filariae and schistosomes Acta Tropica 1996 62: 171–182
Heinecke JW . Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis Curr Opinion Lip 1997 8: 268–274
Hazen SL, Heinecke JW . 3-chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoproteins isolated from human atherosclerotic intima J Clin Invest 1997 99: 2075–2081
Barone FC, Hillegas LM, Price WJ et al. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification J Neurosci Res 1991 29: 336–345
Hudome S, Palmer C, Roberts RL, Mauger D, Housman C, Towfighi J . The role of neutrophils in the production of hypoxic-ischemic brain injury in the neonatal rat Pediatr Res 1997 41: 607–616
Re G, Azzimondi G, Bassein L, Vaona I, Guarnieri C . Plasma lipoperoxidative markers in ischaemic stroke suggest brain embolism Eur J Emerg Med 1997 4: 5–9
MacMahon S, Peto R, Cutler J et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias Lancet 1990 335: 765–774
Kristal B, Shurtz-Swirski R, Manaster J et al. Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension Am J Hypertension 1998 11: 921–928
Piedrafita FJ, Molander RB, Vansant G, Orlova EA, Pfahl M, Reynolds WF . An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element J Biol Chem 1996 271: 14412–14420
Reynolds WF, Chang E, Douer D, Ball ED, Kanda V . An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia Blood 1997 90: 2730–2737
Reynolds WF, Rhees J, Maciejewski D et al. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease Exp Neurol 1999 155: 31–41
Nagra RM, Becher B, Tourtelotte WW et al. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis J Neuroimmunol 1997 78: 97–107
London SJ, Lehman TA, Taylor JA . Myeloperoxidase genetic polymorphism and lung cancer risk Cancer Res 1997 57: 5001–5003
Christensen RD, Rothstein G . Neutrophil MPO concentration: changes with development and during bacterial infection Pediatr Res 1985 19: 1278–1282
Kabutomori O, Yanagihara T, Iwatana Y, Kawarazaki A, Kabuomori M . Sex difference in MPO activity of neutrophils Am J Hematol 1999 60: 312–313
Bain BJ, Gresham N, Addison G . High neutrophil MPO content in smokers Blood 1992 80: 845–846
Dash S, Sen S, Behera D . High neutrophil MPO activity in smokers Blood 1991 77: 1619
Siest G, Visvikis S, Herbeth B et al. Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: the Stanislas Cohort Clin Chem Lab Med 1998 36: 35–42
Donger C, Georges JL, Nicaud V et al. New polymorphisms in the interleukin-10 gene. Relationships to myocardial infarction Eur J Clin Invest 2000 30: 1–7
Cambien F, Poirier O, Nicaud V et al. Sequence diversity in 36 candidate genes for cardiovascular disorders Am J Hum Genet 1999 65: 183–191
Saiki RK, Bugawan TL, Horn GT, Mullis KB, Horn HA . Analysis of enzymatically amplified beta-globin and HLA-DQA alpha DNA with allele-specific oligonucleotide probes Nature 1986 324: 163–166
Liang KY, Zeger SL . Longitudinal data analysis using generalized linear models Biometrika 1986 73: 13–22
Trégouët DA, Ducimetière P, Tiret L . Testing association between candidate-gene markers and phenotype in related individuals, by use of estimating equations Am J Hum Genet 1997 61: 189–199
Donner A, Koval JJ . A multivariate analysis of family data Am J Epidemiol 1981 114: 149–154
Tiret L, Amouyel P, Rakotovao R, Cambien F, Ducimetière P . Testing for association between disease and linked marker loci: a log-linear model analysis Am J Hum Genet 1991 48: 926–934
Schneider S, Roessli D, Excouffier L . Arlequin ver. 2.000: A software for population genetics data analysis. Genetics and Biometry Laboratory, University of Geneva, Switzerland 2000
Allison DB . Transmission disequilibrium tests for quantitative traits Am J Hum Genet 1997 60: 676–690
Trégouët DA, Pallaud C, Sass C, Visvikis S, Tiret L . Sample size calculations for classical association and TDT-type methods using family data Ann Hum Genet 2001 65: 293–312
DeLeo FR, Goedken M, McCormick SJ, Nauseef WM . A novel form of hereditary myeloperoxidase deficiency linked to endoplasmic reticulum/proteasome degradation J Clin Invest 1998 101: 2900–2909
Romano M, Dri P, Dadalt L, Patriarca P, Baralle FE . Biochemical and molecular characterization of hereditary myeloperoxidase deficiency Blood 1997 90: 4126–4134
Nauseef WM, Brigham S, Cogley M . Hereditary myeloperoxidase deficiency due to a missense mutation of arginine 569 to tryptophan J Biol Chem 1994 269: 1212–1216
Wang DG, Fan JB, Siao CJ et al. Large-scale identification, mapping and genotyping of single nucleotide polymorphisms in the human genome Science 1998 280: 1077–1082
Bury TB, Pirnay F . Effect of prolonged exercise on neutrophil myeloperoxidase secretion Int J Sports Med 1995 16: 410–412
Nakamuta M, Ohashi M, Fukutomi T, Tanabe Y, Hiroshige K, Nawata H . Rise of plasma myeloperoxidase during interferon therapy J Gastroenterol Hepatol 1995 10: 277–280
Mohacsi A, Kozlovszky B, Kiss I, Seres I, Fulop T . Neutrophils obtained from obliterative atherosclerotic patients exhibit enhanced resting respiratory burst and increased degranulation in response to various stimuli Biochim Biophys Acta 1996 1316: 210–216
Suzuki K, Swenson C, Sasagawa S et al. Age-related decline in lysosomal enzyme release from polymorphonuclear leukocytes after N-formyl-methionyl-leucyl-phenylalanine stimulation Exp Hematol 1983 11: 1005–1013
Van Eeden SF, Hogg JC . The response of human bone marrow to chronic cigarette smoking Eur Respir J 2000 15: 915–921
Pitzer JE, Del Zoppo GJ, Schmid-Schönbein GW . Neutrophil activation in smokers Biorheology 1996 33: 45–58
Jay M, Kojima S, Gillepsie MN . Nicotine potentiates superoxide anion generation by human neutrophils Toxicol Appl Pharmacol 1986 86: 484–487
Bekesi G, Kakucs R, Varbiro S et al. In vitro effects of different steroid hormones on superoxide anion production of human neutrophil granulocytes Steroids 2000 65: 889–894
Santanam N, Shern-Brewer R, McClatchey R et al. Estradiol as an antioxidant : incompatible with its physiological concentrations and function J Lipid Res 1998 39: 2111–2118
Jansson G . Oestrogen-induced enhancement of myeloperoxidase activity in human polymorphonuclear leukocytes-a possible cause of oxidative stress in inflammatory cells Free Radic Res Commun 1991 14: 195–208
Kutter D, Devaquet P, Vanderstocken G, Paulus JM, Marchal V, Gothot A . Consequences of total and subtotal MPO deficiency: risk or benefit? Acta Haematol 2000 104: 10–15
Reynolds WF, Hiltunen M, Pirskanen M et al. MPO and apoE ε4 polymorphisms interact to increase risk for AD in finnish males Neurology 2000 55: 1284–1290
Utermann G, Kindermann I, Kaffarnik H, Steinmetz A . Apolipoprotein E phenotypes and hyperlipidemia Hum Genet 1984 65: 232–236
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hoy, A., Trégouët, D., Leininger-Muller, B. et al. Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms. Eur J Hum Genet 9, 780–786 (2001). https://doi.org/10.1038/sj.ejhg.5200702
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejhg.5200702
Keywords
This article is cited by
-
Taurine supplementation reduces myeloperoxidase and matrix-metalloproteinase-9 levels and improves the effects of exercise in cognition and physical fitness in older women
Amino Acids (2021)
-
Collagen catabolism through Coll2-1 and Coll2-1NO2 and myeloperoxidase activity in marathon runners
SpringerPlus (2013)
-
Neutrophil Myeloperoxidase: Soldier and Statesman
Archivum Immunologiae et Therapiae Experimentalis (2012)
-
Effects of myeloperoxidase −463 G/A gene polymorphism and plasma levels on coronary artery disease
Molecular Biology Reports (2011)
-
Myeloperoxidase: a target for new drug development?
British Journal of Pharmacology (2007)